InVatin Technologies has developed SYNAXIS-XT, an aortic arch uni-axial diverter designed to deliver embolic protection to the three arteries ascending from the aortic arch, thereby minimizing the risk for cerebral ischemic stroke.

The company's device provides a mechanical barrier, redirecting the emboli away from the brain while preserving blood flow patterns and maintaining uncompromised stent patency. This technology can help prevent stroke in high-risk patients, regardless of the origin of the embolic substance.